• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia
Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia, Published online: 26 April 2019; doi:10.1038/s41417-019-0095-9Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia
Source: Cancer Gene Therapy - April 25, 2019 Category: Cancer & Oncology Authors: Yiqian Wang Ying Xie Jacob Williams Yu Hang Lisa Richter Michelle Becker Catalina Amador David Oupick ý R. Katherine Hyde Source Type: research

The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA
A Jebali
Source: Cancer Gene Therapy - September 8, 2016 Category: Cancer & Oncology Authors: L Kamrani Moghaddam S Ramezani Paschepari M A Zaimy A Abdalaian A Jebali Source Type: research

Precise and efficient siRNA design: a key point in competent gene silencing
-Toolabi
Source: Cancer Gene Therapy - March 18, 2016 Category: Cancer & Oncology Authors: E FakhrF ZareL Teimoori-Toolabi Source Type: research

Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment
J A Kim
Source: Cancer Gene Therapy - September 25, 2015 Category: Cancer & Oncology Authors: M ZhangL YanJ A Kim Source Type: research

Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells
maagacli
Source: Cancer Gene Therapy - June 6, 2014 Category: Cancer & Oncology Authors: M KoldehoffD W BeelenA H Elmaagacli Source Type: research

Additive antileukemia effects by GFI1B- and BCR–ABL-specific siRNA in advanced phase chronic myeloid leukemic cells
Additive antileukemia effects by GFI1B- and BCR–ABL-specific siRNA in advanced phase chronic myeloid leukemic cells Cancer Gene Therapy advance online publication, June 21 2013. doi:10.1038/cgt.2013.31 Authors: M Koldehoff, J L Zakrzewski, D W Beelen & A H Elmaagacli
Source: Cancer Gene Therapy - June 21, 2013 Category: Cancer & Oncology Authors: M KoldehoffJ L ZakrzewskiD W BeelenA H Elmaagacli Tags: advanced leukemia BCR–ABL GFI1B K562 small interfering RNA Source Type: research

Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells
& H Uludağ
Source: Cancer Gene Therapy - March 1, 2013 Category: Cancer & Oncology Authors: H M AliabadiP MahdipoorH Uludağ Tags: lipophilic polymers Mcl-1 multidrug resistance P-glycoprotein siRNA delivery Source Type: research